FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022202314> ?p ?o ?g. }

• W3022202314 abstract "Background: No studies have yet clarified the mechanism of acquired resistance to insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase inhibitor (TKI). Our previous study of 16 breast cancer cell lines found that only MCF-7 expressed high levels of insulin receptor substrate (IRS)-1 and was sensitive to the IGF-1R-TKI NVP-AEW541. Material and Methods: We developed a model of acquired resistance to NVP-AEW541 by continuously exposing MCF-7 cells to NVP-AEW541, naming the model MCF-7-NR. To explore the mechanism of acquired resistance to NVP-AEW541, the effects of NVP-AEW541 on cell growth and IGF-1R signaling in MCF-7 and MCF-7-NR cells were examined. Results: With Western blot analysis, we found that MCF-7-NR had much lower levels of IRS-1 than parental MCF-7. While phosphorylation of Akt was completely inhibited by administration of NVP-AEW541 (3 μM) in both cell lines, phosphorylation of S6K remained high only in MCF-7-NR. The notion of Akt-independent S6K phosphorylation in MCF-7-NR was further supported by the fact that cell growth and phosphorylation of S6K was affected by administration of the Akt inhibitor perifosine to a lesser degree in MCF-7-NR than in MCF-7. Further, the mTOR inhibitor everolimus inhibited phosphorylation of S6K and cell growth equally in both lines. Screening of MCF-7 and MCF-7-NR lines for phosphorylation of 42 receptor tyrosine kinases with and without 3μM NVP-AEW541 showed that Tyro3 phosphorylation remained high only in MCF-7-NR cells. Gene silencing of Tyro3 using siRNA resulted in reduced cell growth, decreased phosphorylation of phosphoinositide-dependent kinase-1 (PDK-1) and protein kinase C α/βII, reduced expression of cyclin D1 in the MCF-7-NR line, with minimal effects evident in the MCF-7 line. Discussion: Findings from our current study support the possibility of predicting sensitivity to NVP-AEW541 by measuring IRS-1 expression, as hypothesized in our previous study. Akt-independent activation of mTOR/S6K by an as-yet-undefined mechanism appears to induce acquired resistance to NVP-AEW541, and as such mTOR inhibitors may have therapeutic value. Tyro3 upregulation and migration of control of cellular growth and cyclin D1 expression may also induce resistance to NVP-AEW541. Although the validity of these findings should be evaluated in further preclinical studies and eventually in clinical trials, our observations may lead to individualized use of NVP-AEW541 and the development of “backup drugs” against tumors that acquire resistance to NVP-AEW541. Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P5-06-04." @default.
• W3022202314 created "2020-05-13" @default.
• W3022202314 creator A5014748794 @default.
• W3022202314 creator A5025983559 @default.
• W3022202314 creator A5030591160 @default.
• W3022202314 creator A5034582186 @default.
• W3022202314 creator A5048631382 @default.
• W3022202314 creator A5064895394 @default.
• W3022202314 date "2011-12-15" @default.
• W3022202314 modified "2023-09-27" @default.
• W3022202314 title "P5-06-04: Mechanisms of Acquired Resistance to Insulin-Like Growth Factor 1 Receptor Inhibitor in MCF-7 Breast Cancer Cell Line." @default.
• W3022202314 doi "https://doi.org/10.1158/0008-5472.sabcs11-p5-06-04" @default.
• W3022202314 hasPublicationYear "2011" @default.
• W3022202314 type Work @default.
• W3022202314 sameAs 3022202314 @default.
• W3022202314 citedByCount "0" @default.
• W3022202314 crossrefType "proceedings-article" @default.
• W3022202314 hasAuthorship W3022202314A5014748794 @default.
• W3022202314 hasAuthorship W3022202314A5025983559 @default.
• W3022202314 hasAuthorship W3022202314A5030591160 @default.
• W3022202314 hasAuthorship W3022202314A5034582186 @default.
• W3022202314 hasAuthorship W3022202314A5048631382 @default.
• W3022202314 hasAuthorship W3022202314A5064895394 @default.
• W3022202314 hasConcept C101544691 @default.
• W3022202314 hasConcept C104202773 @default.
• W3022202314 hasConcept C109541995 @default.
• W3022202314 hasConcept C11960822 @default.
• W3022202314 hasConcept C121608353 @default.
• W3022202314 hasConcept C126322002 @default.
• W3022202314 hasConcept C170493617 @default.
• W3022202314 hasConcept C185592680 @default.
• W3022202314 hasConcept C2775960820 @default.
• W3022202314 hasConcept C2777553839 @default.
• W3022202314 hasConcept C2780689927 @default.
• W3022202314 hasConcept C2994423619 @default.
• W3022202314 hasConcept C502942594 @default.
• W3022202314 hasConcept C55493867 @default.
• W3022202314 hasConcept C62112901 @default.
• W3022202314 hasConcept C62478195 @default.
• W3022202314 hasConcept C71924100 @default.
• W3022202314 hasConcept C75217442 @default.
• W3022202314 hasConcept C86554907 @default.
• W3022202314 hasConcept C86803240 @default.
• W3022202314 hasConcept C95444343 @default.
• W3022202314 hasConcept C96232424 @default.
• W3022202314 hasConceptScore W3022202314C101544691 @default.
• W3022202314 hasConceptScore W3022202314C104202773 @default.
• W3022202314 hasConceptScore W3022202314C109541995 @default.
• W3022202314 hasConceptScore W3022202314C11960822 @default.
• W3022202314 hasConceptScore W3022202314C121608353 @default.
• W3022202314 hasConceptScore W3022202314C126322002 @default.
• W3022202314 hasConceptScore W3022202314C170493617 @default.
• W3022202314 hasConceptScore W3022202314C185592680 @default.
• W3022202314 hasConceptScore W3022202314C2775960820 @default.
• W3022202314 hasConceptScore W3022202314C2777553839 @default.
• W3022202314 hasConceptScore W3022202314C2780689927 @default.
• W3022202314 hasConceptScore W3022202314C2994423619 @default.
• W3022202314 hasConceptScore W3022202314C502942594 @default.
• W3022202314 hasConceptScore W3022202314C55493867 @default.
• W3022202314 hasConceptScore W3022202314C62112901 @default.
• W3022202314 hasConceptScore W3022202314C62478195 @default.
• W3022202314 hasConceptScore W3022202314C71924100 @default.
• W3022202314 hasConceptScore W3022202314C75217442 @default.
• W3022202314 hasConceptScore W3022202314C86554907 @default.
• W3022202314 hasConceptScore W3022202314C86803240 @default.
• W3022202314 hasConceptScore W3022202314C95444343 @default.
• W3022202314 hasConceptScore W3022202314C96232424 @default.
• W3022202314 hasLocation W30222023141 @default.
• W3022202314 hasOpenAccess W3022202314 @default.
• W3022202314 hasPrimaryLocation W30222023141 @default.
• W3022202314 hasRelatedWork W1514895596 @default.
• W3022202314 hasRelatedWork W2023113466 @default.
• W3022202314 hasRelatedWork W2029682365 @default.
• W3022202314 hasRelatedWork W2033577857 @default.
• W3022202314 hasRelatedWork W2040823865 @default.
• W3022202314 hasRelatedWork W2104437706 @default.
• W3022202314 hasRelatedWork W2120093145 @default.
• W3022202314 hasRelatedWork W2125251091 @default.
• W3022202314 hasRelatedWork W2137993244 @default.
• W3022202314 hasRelatedWork W2279964776 @default.
• W3022202314 hasRelatedWork W2290890779 @default.
• W3022202314 hasRelatedWork W2315748247 @default.
• W3022202314 hasRelatedWork W2332606004 @default.
• W3022202314 hasRelatedWork W2334005112 @default.
• W3022202314 hasRelatedWork W2566856818 @default.
• W3022202314 hasRelatedWork W2571886330 @default.
• W3022202314 hasRelatedWork W2605037335 @default.
• W3022202314 hasRelatedWork W2948535740 @default.
• W3022202314 hasRelatedWork W866175197 @default.
• W3022202314 hasRelatedWork W2187781040 @default.
• W3022202314 isParatext "false" @default.
• W3022202314 isRetracted "false" @default.
• W3022202314 magId "3022202314" @default.
• W3022202314 workType "article" @default.